Targeted therapy of hepatocellular carcinoma: present and future.
about
Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinomaClusterin: Review of research progress and looking ahead to direction in hepatocellular carcinomaSystemic treatment for inoperable pancreatic adenocarcinoma: review and updateManagement of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma.Magnetic alginate microspheres detected by MRI fabricated using microfluidic technique and release behavior of encapsulated dual drugsKCTD11 inhibits growth and metastasis of hepatocellular carcinoma through activating Hippo signalingDihydromyricetin induces apoptosis and inhibits proliferation in hepatocellular carcinoma cells.Drug development for hepatocellular carcinoma: knowing the past helps to understand the futurePreclinical trials for prevention of tumor progression of hepatocellular carcinoma by LZ-8 targeting c-Met dependent and independent pathways.Reciprocal activating crosstalk between c-Met and caveolin 1 promotes invasive phenotype in hepatocellular carcinoma.Evaluating the role of treatment-related toxicities in the challenges facing targeted therapies for advanced hepatocellular carcinoma.Huaier polysaccharide induces apoptosis in hepatocellular carcinoma cells through p38 MAPK.Antiangiogenic and antihepatocellular carcinoma activities of the Juniperus chinensis extract.Hepatocellular Carcinoma Patients With Performance Status 1 Deserve New Classification and Treatment Algorithm in the BCLC System.Interaction of the hepatitis B spliced protein with cathepsin B promotes hepatoma cell migration and invasion.Targeting late SV40 factor: is the achilles heel of hepatocarcinogenesis revealed?Epigenetics in hepatocellular carcinoma: an update and future therapy perspectives.Circulating Tumor DNA Analysis for Liver Cancers and Its Usefulness as a Liquid Biopsy.TGF-β Mediated Crosstalk Between Malignant Hepatocyte and Tumor Microenvironment in Hepatocellular Carcinoma.Recombinant adeno-associated virus expressing a p53-derived apoptotic peptide (37AA) inhibits HCC cells growth in vitro and in vivo.Anti-angiogenic drug discovery: lessons from the past and thoughts for the future.Targeted therapies in the treatment of advanced hepatocellular carcinomaDevelopment of systemic therapy for hepatocellular carcinoma at 2013: updates and insights.Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinomaMolecular targeted therapy in hepatocellular carcinoma: from biology to clinical practice and future.Novel therapeutic targets and predictive markers for hepatocellular carcinoma.A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1.The downregulation of ErbB3 binding protein 1 (EBP1) is associated with poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.Benzylidene-indolinones are effective as multi-targeted kinase inhibitor therapeutics against hepatocellular carcinoma.Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinoma.Proteomics approaches for early detection and targeted therapy of hepatocellular carcinoma.Factors Associated with Post-Progression Survival in Patients with Advanced Hepatocellular Carcinoma Treated with SorafenibTargeting DTL induces cell cycle arrest and senescence and suppresses cell growth and colony formation through TPX2 inhibition in human hepatocellular carcinoma cells.Suppression of the nuclear transporter-KPNβ1 expression inhibits tumor proliferation in hepatocellular carcinoma.Anti-proliferative Effect of 15,16-Dihydrotanshinone I Through Cell Cycle Arrest and the Regulation of AMP-activated Protein Kinase/Akt/mTOR and Mitogen-activated Protein Kinase Signaling Pathway in Human Hepatocellular Carcinoma Cells.Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications
P2860
Q26784412-F163BB77-1594-4BAC-BB16-B7EA833849EBQ26799048-52DA235F-FD32-4F62-A453-09CAFC4BB71BQ26830913-054D85E6-2143-418F-AE7D-475EE1FD4702Q28072595-8FEC6310-E0F6-495E-9412-66A7CCE85951Q33723810-BD729D65-9ABF-410A-94A6-32F8C1563789Q33807180-D7733421-5D5F-4922-A137-CDE94EF92E8FQ33914111-DECF1F55-77D5-4864-A8BC-985A676817C7Q34141891-AE2BFC2F-4E8D-46DE-A4E9-ABEABC177ABEQ34458068-B34EE37B-1E0D-46C0-92F0-470919A7B0E5Q34995167-1ECCB93B-A066-4521-87E9-8294247C27AEQ35229808-D3B0EF99-E175-42EC-B852-C5C4CB7BC916Q35739362-C7CBC9BC-3768-45FF-BF0C-4C44D7562315Q36083511-456E9524-C028-4EA0-B744-56AFCF859C73Q36097965-F4348947-1E9E-430B-BB15-12ECCEAC9DDDQ36153539-22755122-1A50-4791-ABAD-C7146C0500CFQ36414502-3354EFD3-AEAE-47AE-B361-C7510A7D1BB8Q36460975-87211B62-7078-4274-A4E8-BF5A8F4EA184Q37581334-A160FB0E-68E6-4815-AE6A-58C585F1CF7CQ37635310-7AD31D03-A0F1-4C77-8681-D456899326ABQ37705967-6D1F2060-8751-400F-BE40-53A9134B2503Q37725521-40C6715D-FF66-46CB-8C06-728BB2F2E01EQ38020234-865BD5DC-B739-4C3D-8213-3ED0690B663FQ38114062-73A38121-552C-4116-ACF9-D081E4174538Q38201707-57F09731-9B39-452B-BB04-13D844E9A73AQ38207013-E4D7C1CA-CC5A-477D-9D27-8EB166B171F5Q38212573-4517319D-E132-4CB8-B6FA-5D40239F1218Q38440838-E1C1C01E-0790-4816-873B-64C3A3051FFBQ38652256-D167577D-63A8-449D-BCE6-909ACBE3483BQ38969791-2CAA484B-EB59-403F-A4C4-98F0C126B1AEQ38993878-B2DDFB0F-FEDD-4D1B-93D9-DDB3BEE3D8A0Q39172796-71F48827-408F-477E-B872-2BFB924BD2E2Q42330057-1F95DF84-1866-4DFC-9473-03E71C18FAD9Q42343440-DA15D06A-512C-4EB1-A192-4FBA8A0B9C90Q52614692-28A4EB09-B8E0-4D1C-B9D0-28860F5B9604Q52957364-98EB4A63-8203-4565-B6ED-AD981795F250Q55544709-FFFFAA0F-6329-46B2-955E-45132BE96377Q58760425-64AE8677-74E9-4775-81FC-189D1D5FFEF9
P2860
Targeted therapy of hepatocellular carcinoma: present and future.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeted therapy of hepatocellular carcinoma: present and future.
@en
Targeted therapy of hepatocellular carcinoma: present and future.
@nl
type
label
Targeted therapy of hepatocellular carcinoma: present and future.
@en
Targeted therapy of hepatocellular carcinoma: present and future.
@nl
prefLabel
Targeted therapy of hepatocellular carcinoma: present and future.
@en
Targeted therapy of hepatocellular carcinoma: present and future.
@nl
P2860
P1476
Targeted therapy of hepatocellular carcinoma: present and future
@en
P2093
Stephen L Chan
Winnie Yeo
P2860
P304
P356
10.1111/J.1440-1746.2012.07096.X
P577
2012-05-01T00:00:00Z